BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 07, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Hepoxal inositol nicotinate regulatory update

Genus Pharmaceuticals Ltd., Newbury, U.K.
Otsuka Pharmaceutical Co. Ltd., Tokyo, Japan
sanofi-aventis Group (Euronext:SAN; NYSE:SNY), Paris, France
Product: Hepoxal inositol nicotinate; Pletal cilostazol; Trental...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >